Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kenneth Alan Bauer, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. P01HL033014 (ROSENBERG, ROBERT D) Dec 1, 1984 - Nov 30, 1994
    NIH/NHLBI
    THROMBOSIS AND ATHEROSCLEROSIS
    Role: Co-Principal Investigator
  2. M01RR001032 (SUKHATME, VIKAS P) Dec 1, 1977 - Nov 30, 2004
    NIH/NCRR
    General Clinical Research Center
    Role: Co-Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Zwicker JI, Roopkumar J, Puligandla M, Schlechter BL, Sharda AV, Peereboom D, Joyce R, Bockorny B, Neuberg D, Bauer KA, Khorana AA. Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial. Blood Adv. 2020 May 26; 4(10):2254-2260. PMID: 32442298.
    Citations:    
  2. Carroll BJ, Beyer SE, Mehegan T, Dicks A, Pribish A, Locke A, Godishala A, Soriano K, Kanduri J, Sack K, Raber I, Wiest C, Balachandran I, Marcus M, Chu L, Hayes MM, Weinstein JL, Bauer KA, Secemsky EA, Pinto DS. Changes in Care for Acute Pulmonary Embolism Through A Multidisciplinary Pulmonary Embolism Response Team. Am J Med. 2020 May 19. PMID: 32416175.
    Citations:    
  3. Neumann I, Izcovich A, Zhang Y, Rada G, Kahn SR, Spencer F, Rezende S, Dentali F, Bauer K, Morgano GP, Yepes-Nuñez JJ, Nieuwlaat R, Wiercioch W, Lu L, Wu J, Cushman M, Schunemann H. DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines. Blood Adv. 2020 Apr 14; 4(7):1512-1517. PMID: 32289163.
    Citations:    
  4. Kanjee Z, Bauer KA, Breu AC, Burns R. Should You Treat This Acutely Ill Medical Inpatient With Venous Thromboembolism Chemoprophylaxis?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Ann Intern Med. 2020 Apr 07; 172(7):484-491. PMID: 32252085.
    Citations:    
  5. Yang S, Bauer KA, Singleton JM, Papavassiliou E, Kramer DB. A Balancing Act. Circulation. 2020 Mar 31; 141(13):1103-1106. PMID: 32223675.
    Citations:    
  6. Moran J, Bauer KA. Managing thromboembolic risk in patients with hereditary and acquired thrombophilias. Blood. 2020 01 30; 135(5):344-350. PMID: 31917425.
    Citations:    
  7. Bauer KA. How Effective and Safe Is Factor XI Inhibition in Preventing Venous Thrombosis? JAMA. 2020 01 14; 323(2):121-122. PMID: 31935013.
    Citations:    
  8. Eche IM, Elsamadisi P, Wex N, Wyers MC, Brat GA, Cunningham K, Bauer KA. Intraoperative Unfractionated Heparin Unresponsiveness during Endovascular Repair of a Ruptured Abdominal Aortic Aneurysm following Administration of Andexanet Alfa for the Reversal of Rivaroxaban. Pharmacotherapy. 2019 08; 39(8):861-865. PMID: 31251821.
    Citations:    
  9. Kearon C, Parpia S, Spencer FA, Schulman S, Stevens SM, Shah V, Bauer KA, Douketis JD, Lentz SR, Kessler CM, Connors JM, Ginsberg JS, Spadafora L, Julian JA. Long-term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d-dimer results; A cohort study. J Thromb Haemost. 2019 07; 17(7):1144-1152. PMID: 31033194.
    Citations:    
  10. Zwicker JI, Schlechter BL, Stopa JD, Liebman HA, Aggarwal A, Puligandla M, Caughey T, Bauer KA, Kuemmerle N, Wong E, Wun T, McLaughlin M, Hidalgo M, Neuberg D, Furie B, Flaumenhaft R. Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer. JCI Insight. 2019 02 21; 4(4). PMID: 30652973.
    Citations:    Fields:    
  11. Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T, Streiff MB, Garcia DA, Liebman HA, Belani CP, O'Reilly EM, Patel JN, Yimer HA, Wildgoose P, Burton P, Vijapurkar U, Kaul S, Eikelboom J, McBane R, Bauer KA, Kuderer NM, Lyman GH. Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer. N Engl J Med. 2019 02 21; 380(8):720-728. PMID: 30786186.
    Citations:    
  12. Schünemann HJ, Cushman M, Burnett AE, Kahn SR, Beyer-Westendorf J, Spencer FA, Rezende SM, Zakai NA, Bauer KA, Dentali F, Lansing J, Balduzzi S, Darzi A, Morgano GP, Neumann I, Nieuwlaat R, Yepes-Nuñez JJ, Zhang Y, Wiercioch W. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018 11 27; 2(22):3198-3225. PMID: 30482763.
    Citations:    
  13. Kearon C, Parpia S, Spencer FA, Baglin T, Stevens SM, Bauer KA, Lentz SR, Kessler CM, Douketis JD, Moll S, Kaatz S, Schulman S, Connors JM, Ginsberg JS, Spadafora L, Bhagirath V, Liaw PC, Weitz JI, Julian JA. Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism. Blood. 2018 05 10; 131(19):2151-2160. PMID: 29490924.
    Citations: 1     Fields:    
  14. Carroll BJ, Pemberton H, Bauer KA, Chu LM, Weinstein JL, Levarge BL, Pinto DS. Initiation of a Multidisciplinary, Rapid Response Team to Massive and Submassive Pulmonary Embolism. Am J Cardiol. 2017 Oct 15; 120(8):1393-1398. PMID: 28807405.
    Citations: 1     Fields:    Translation:Humans
  15. Bauer KA. The challenge of hospital-related thrombosis. Blood. 2017 07 13; 130(2):97-98. PMID: 28705852.
    Citations:    Fields:    Translation:Humans
  16. Ganetsky M, Lopez G, Coreanu T, Novack V, Horng S, Shapiro NI, Bauer KA. Risk of Intracranial Hemorrhage in Ground-level Fall With Antiplatelet or Anticoagulant Agents. Acad Emerg Med. 2017 10; 24(10):1258-1266. PMID: 28475282.
    Citations: 1     Fields:    Translation:Humans
  17. James AH, Bates SM, Bauer KA, Branch W, Mann K, Paidas M, Silverman N, Konkle BA. Management of hereditary antithrombin deficiency in pregnancy. Thromb Res. 2017 Sep; 157:41-45. PMID: 28689083.
    Citations: 1     Fields:    Translation:Humans
  18. Stolla M, Chang S, Schulman S, Bauer K, Haspel R, Lerner AB. Use of thromboelastography in the management of a patient with acquired von Willebrand disease undergoing cardiac bypass surgery. Br J Haematol. 2018 04; 181(1):143-145. PMID: 28106909.
    Citations:    Fields:    
  19. Kearon C, Parpia S, Spencer FA, Baglin T, Stevens SM, Bauer KA, Lentz SR, Kessler CM, Douketis JD, Moll S, Kaatz S, Schulman S, Connors JM, Ginsberg JS, Spadafora L, Liaw PC, Weitz JI, Julian JA. D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment. Thromb Res. 2016 Oct; 146:119-125. PMID: 27354153.
    Citations:    Fields:    Translation:Humans
  20. Bauer KA, Nguyen-Cao TM, Spears JB. Issues in the Diagnosis and Management of Hereditary Antithrombin Deficiency. Ann Pharmacother. 2016 09; 50(9):758-67. PMID: 27281301.
    Citations:    Fields:    Translation:Humans
  21. McLintock C, Pabinger I, Bauer KA, Laffan M, Angchaisuksiri P, Rezende SM, Middeldorp S, Ross M. International Society on Thrombosis and Haemostasis core curriculum project: core competencies in clinical thrombosis and hemostasis. J Thromb Haemost. 2016 Jan; 14(1):3-27. PMID: 26439670.
    Citations: 1     Fields:    Translation:Humans
  22. Stevens SM, Woller SC, Bauer KA, Kasthuri R, Cushman M, Streiff M, Lim W, Douketis JD. Guidance for the evaluation and treatment of hereditary and acquired thrombophilia. J Thromb Thrombolysis. 2016 Jan; 41(1):154-64. PMID: 26780744.
    Citations: 7     Fields:    Translation:Humans
  23. Bauer KA. Targeted Anti-Anticoagulants. N Engl J Med. 2015 Aug 06; 373(6):569-71. PMID: 26095632.
    Citations: 7     Fields:    Translation:Humans
  24. Bauer KA. Current challenges in the management of hemophilia. Am J Manag Care. 2015 Mar; 21(6 Suppl):S112-22. PMID: 26168206.
    Citations: 1     Fields:    Translation:Humans
  25. Kearon C, Spencer FA, O'Keeffe D, Parpia S, Schulman S, Baglin T, Stevens SM, Kaatz S, Bauer KA, Douketis JD, Lentz SR, Kessler CM, Moll S, Connors JM, Ginsberg JS, Spadafora L, Julian JA. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. Ann Intern Med. 2015 Jan 06; 162(1):27-34. PMID: 25560712.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  26. Crowther M, Bauer KA, Kaplan AP. The thrombogenicity of C1 esterase inhibitor (human): review of the evidence. Allergy Asthma Proc. 2014 Nov-Dec; 35(6):444-53. PMID: 25584911.
    Citations: 6     Fields:    Translation:HumansAnimals
  27. Zwicker JI, Bauer KA. How long is long enough? Extended anticoagulation for the treatment of cancer-associated deep vein thrombosis. J Clin Oncol. 2014 Nov 10; 32(32):3596-9. PMID: 25267753.
    Citations:    Fields:    Translation:Humans
  28. Lubitz SA, Bauer KA, Benjamin EJ, Besdine RW, Forman DE, Gurol ME, Reddy VY, Singer DE. Stroke prevention in atrial fibrillation in older adults: existing knowledge gaps and areas for innovation: a summary of an American Federation for Aging research seminar. J Am Geriatr Soc. 2013 Oct; 61(10):1798-803. PMID: 24083473.
    Citations: 5     Fields:    Translation:Humans
  29. Steinberg BA, Beckley PD, Deering TF, Clark CL, Amin AN, Bauer KA, Cryer B, Mansour M, Scheiman JM, Zenati MA, Newby LK, Peacock WF, Bhatt DL. Evaluation and management of the atrial fibrillation patient: a report from the Society of Cardiovascular Patient Care. Crit Pathw Cardiol. 2013 Sep; 12(3):107-15. PMID: 23892939.
    Citations: 1     Fields:    Translation:Humans
  30. Bauer KA. Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal. Stroke. 2013 Jun; 44(6 Suppl 1):S38-40. PMID: 23709725.
    Citations: 2     Fields:    Translation:Humans
  31. James AH, Konkle BA, Bauer KA. Prevention and treatment of venous thromboembolism in pregnancy in patients with hereditary antithrombin deficiency. Int J Womens Health. 2013; 5:233-41. PMID: 23662090.
    Citations: 6     
  32. Bauer KA. Pros and cons of new oral anticoagulants. Hematology Am Soc Hematol Educ Program. 2013; 2013:464-70. PMID: 24319220.
    Citations: 44     Fields:    Translation:Humans
  33. Zwicker JI, Liebman HA, Bauer KA, Caughey T, Campigotto F, Rosovsky R, Mantha S, Kessler CM, Eneman J, Raghavan V, Lenz HJ, Bullock A, Buchbinder E, Neuberg D, Furie B. Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study). Br J Haematol. 2013 Feb; 160(4):530-7. PMID: 23240761.
    Citations: 16     Fields:    Translation:HumansCellsCTClinical Trials
  34. Mantha S, Karp R, Raghavan V, Terrin N, Bauer KA, Zwicker JI. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ. 2012 Aug 07; 345:e4944. PMID: 22872710.
    Citations: 16     Fields:    Translation:Humans
  35. Feinbloom D, Bauer KA. ACP Journal Club. Enoxaparin thrombophylaxis did not reduce mortality in acutely ill medical patients. Ann Intern Med. 2012 Apr 17; 156(8):JC4-06. PMID: 22508746.
    Citations:    Fields:    
  36. Baglin T, Bauer K, Douketis J, Buller H, Srivastava A, Johnson G. Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH. J Thromb Haemost. 2012 Apr; 10(4):698-702. PMID: 22332937.
    Citations: 11     Fields:    Translation:Humans
  37. Bauer KA. Reversal of antithrombotic agents. Am J Hematol. 2012 May; 87 Suppl 1:S119-26. PMID: 22460529.
    Citations: 11     Fields:    Translation:Humans
  38. Bauer KA. Recent progress in anticoagulant therapy: oral direct inhibitors of thrombin and factor Xa. J Thromb Haemost. 2011 Jul; 9 Suppl 1:12-9. PMID: 21781237.
    Citations: 19     Fields:    Translation:Humans
  39. Battinelli EM, Bauer KA. Thrombophilias in pregnancy. Hematol Oncol Clin North Am. 2011 Apr; 25(2):323-33, viii. PMID: 21444033.
    Citations: 2     Fields:    Translation:Humans
  40. Bauer KA. Long-term management of venous thromboembolism: a 61-year-old woman with unprovoked venous thromboembolism. JAMA. 2011 Apr 06; 305(13):1336-45. PMID: 21386068.
    Citations: 1     Fields:    Translation:Humans
  41. Bauer KA, Gerson W, Wright C, Wang J, McNicol E, Lanier RK, Kramer W, Carr DB. Platelet function following administration of a novel formulation of intravenous diclofenac sodium versus active comparators: a randomized, single dose, crossover study in healthy male volunteers. J Clin Anesth. 2010 Nov; 22(7):510-8. PMID: 21056807.
    Citations: 3     Fields:    Translation:HumansCells
  42. Ken-Dror G, Drenos F, Humphries SE, Talmud PJ, Hingorani AD, Kivimäki M, Kumari M, Bauer KA, Morrissey JH, Ireland HA. Haplotype and genotype effects of the F7 gene on circulating factor VII, coagulation activation markers and incident coronary heart disease in UK men. J Thromb Haemost. 2010 Nov; 8(11):2394-403. PMID: 20735728.
    Citations: 6     Fields:    Translation:Humans
  43. Lopaciuk S, Windyga J, Watala CW, Bykowska K, Pietrucha T, Kwiecinski H, Czlonkowska A, Kuczynska-Zardzewialy A, Jackson AA, Carew JA, Bauer KA. Polymorphisms in the factor VII gene and ischemic stroke in young adults. Blood Coagul Fibrinolysis. 2010 Jul; 21(5):442-7. PMID: 20453637.
    Citations: 2     Fields:    Translation:Humans
  44. Bauer KA. Thrombophilia evaluation: the value of testing relatives. Clin Adv Hematol Oncol. 2010 Apr; 8(4):229-31. PMID: 20505643.
    Citations:    Fields:    Translation:Humans
  45. Arepally G, Bauer KA, Bhatt DL, Merli GJ, Naccarelli GV, Carter RD, Karcher RB, Berry CA, Keaton KL, Stowell SA. The use of antithrombotic therapies in the prevention and treatment of arterial and venous thrombosis: a survey of current knowledge and practice supporting the need for clinical education. Crit Pathw Cardiol. 2010 Mar; 9(1):41-8. PMID: 20215910.
    Citations: 3     Fields:    Translation:Humans
  46. Bauer KA. New oral anticoagulants in development: potential for improved safety profiles. Rev Neurol Dis. 2010; 7(1):1-8. PMID: 20410856.
    Citations: 1     Fields:    Translation:Humans
  47. Bauer KA. Duration of anticoagulation: applying the guidelines and beyond. Hematology Am Soc Hematol Educ Program. 2010; 2010:210-5. PMID: 21239796.
    Citations: 1     Fields:    Translation:Humans
  48. Mantha S, Bauer KA, Zwicker JI. Low molecular weight heparin to achieve live birth following unexplained pregnancy loss: a systematic review. J Thromb Haemost. 2010 Feb; 8(2):263-8. PMID: 19912516.
    Citations: 4     Fields:    Translation:Humans
  49. Zwicker JI, Liebman HA, Neuberg D, Lacroix R, Bauer KA, Furie BC, Furie B. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res. 2009 Nov 15; 15(22):6830-40. PMID: 19861441.
    Citations: 101     Fields:    Translation:Humans
  50. Ireland HA, Cooper JA, Drenos F, Acharya J, Mitchell JP, Bauer KA, Morrissey JH, Esnouf MP, Humphries SE. FVII, FVIIa, and downstream markers of extrinsic pathway activation differ by EPCR Ser219Gly variant in healthy men. Arterioscler Thromb Vasc Biol. 2009 Nov; 29(11):1968-74. PMID: 19696402.
    Citations: 10     Fields:    Translation:Humans
  51. Turpie AG, Lassen MR, Davidson BL, Bauer KA, Gent M, Kwong LM, Cushner FD, Lotke PA, Berkowitz SD, Bandel TJ, Benson A, Misselwitz F, Fisher WD. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet. 2009 May 16; 373(9676):1673-80. PMID: 19411100.
    Citations: 167     Fields:    Translation:HumansCTClinical Trials
  52. Jackson D, White I, Kostis JB, Wilson AC, Folsom AR, Wu K, Chambless L, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, de Maat MP, Thompson SG, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi V, Vahtera E, Jousilahti P, D'Agostino R, Kannel WB, Wilson PW, Tofler G, Levy D, Marchioli R, Valagussa F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen J, Nyyssönen K, Tuomainen TP, Hedblad B, Engström G, Berglund G, Loewel H, Koenig W, Hense HW, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A, Naito Y, Iso H, Salomaa V, Harald K, Rasi V, Vahtera E, Jousilahti P, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Despres JP, Dagenais GR, Tunstall-Pedoe H, Lowe GD, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh JL, Meade TW, Rudnicka A, Brennan P, Knottenbelt C, Cooper JA, Ridker P, Rodeghiero F, Tosetto A, Shepherd J, Lowe GD, Ford I, Robertson M, Brunner E, Shipley M, Feskens EJ, Di Angelantonio E, Kaptoge S, Lewington S, Lowe GD, Sarwar N, Thompson SG, Walker M, Watson S, White IR, Wood AM, Danesh J. Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med. 2009 Apr 15; 28(8):1218-37. PMID: 19222087.
    Citations: 15     Fields:    Translation:Humans
  53. Bezemer ID, Arellano AR, Tong CH, Rowland CM, Ireland HA, Bauer KA, Catanese J, Reitsma PH, Doggen CJ, Devlin JJ, Rosendaal FR, Bare LA. F9 Malmö, factor IX and deep vein thrombosis. Haematologica. 2009 May; 94(5):693-9. PMID: 19286883.
    Citations: 4     Fields:    Translation:HumansCells
  54. Turpie AG, Bauer KA, Davidson BL, Fisher WD, Gent M, Huo MH, Sinha U, Gretler DD. A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT). Thromb Haemost. 2009 Jan; 101(1):68-76. PMID: 19132191.
    Citations: 21     Fields:    Translation:Humans
  55. Haspel J, Bauer K, Goehler A, Roberts DH. Long-term anticoagulant therapy for idiopathic pulmonary embolism in the elderly: a decision analysis. Chest. 2009 May; 135(5):1243-1251. PMID: 19017863.
    Citations: 1     Fields:    Translation:Humans
  56. Fine G, Bauer K, Al-Mohaya M, Woo SB. Successful treatment of ligneous gingivitis with warfarin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Jan; 107(1):77-80. PMID: 18996031.
    Citations: 5     Fields:    Translation:Humans
  57. Bauer KA. New anticoagulants. Curr Opin Hematol. 2008 Sep; 15(5):509-15. PMID: 18695376.
    Citations: 8     Fields:    Translation:Humans
  58. Hirsh J, Bauer KA, Donati MB, Gould M, Samama MM, Weitz JI. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun; 133(6 Suppl):141S-159S. PMID: 18574264.
    Citations: 107     Fields:    Translation:Humans
  59. Freedman RA, Bauer KA, Neuberg DS, Zwicker JI. Timing of postpartum enoxaparin administration and severe postpartum hemorrhage. Blood Coagul Fibrinolysis. 2008 Jan; 19(1):55-9. PMID: 18180616.
    Citations: 1     Fields:    Translation:Humans
  60. Mueck W, Eriksson BI, Bauer KA, Borris L, Dahl OE, Fisher WD, Gent M, Haas S, Huisman MV, Kakkar AK, Kälebo P, Kwong LM, Misselwitz F, Turpie AG. Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery. Clin Pharmacokinet. 2008; 47(3):203-16. PMID: 18307374.
    Citations: 51     Fields:    Translation:HumansCTClinical Trials
  61. Miller GJ, Ireland HA, Cooper JA, Bauer KA, Morrissey JH, Humphries SE, Esnouf MP. Relationship between markers of activated coagulation, their correlation with inflammation, and association with coronary heart disease (NPHSII). J Thromb Haemost. 2008 Feb; 6(2):259-67. PMID: 17973650.
    Citations: 10     Fields:    Translation:HumansCells
  62. Danesh J, Erqou S, Walker M, Thompson SG, Tipping R, Ford C, Pressel S, Walldius G, Jungner I, Folsom AR, Chambless LE, Knuiman M, Whincup PH, Wannamethee SG, Morris RW, Willeit J, Kiechl S, Santer P, Mayr A, Wald N, Ebrahim S, Lawlor DA, Yarnell JW, Gallacher J, Casiglia E, Tikhonoff V, Nietert PJ, Sutherland SE, Bachman DL, Keil JE, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Nordestgaard BG, Frikke-Schmidt R, Giampaoli S, Palmieri L, Panico S, Vanuzzo D, Pilotto L, Simons L, McCallum J, Friedlander Y, Fowkes FG, Lee AJ, Smith FB, Taylor J, Guralnik J, Phillips C, Wallace R, Blazer D, Khaw KT, Jansson JH, Donfrancesco C, Salomaa V, Harald K, Jousilahti P, Vartiainen E, Woodward M, D'Agostino RB, Wolf PA, Vasan RS, Pencina MJ, Bladbjerg EM, Jorgensen T, Moller L, Jespersen J, Dankner R, Chetrit A, Lubin F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Bjorkelund C, Cremer P, Nagel D, Tilvis R, Strandberg T, Rodriguez B, Bouter LM, Heine RJ, Dekker JM, Nijpels G, Stehouwer CD, Rimm E, Pai J, Sato S, Iso H, Kitamura A, Noda H, Goldbourt U, Salomaa V, Salonen JT, Nyyssönen K, Tuomainen TP, Deeg D, Poppelaars JL, Meade T, Cooper J, Hedblad B, Berglund G, Engstrom G, Döring A, Koenig W, Meisinger C, Mraz W, Kuller L, Selmer R, Tverdal A, Nystad W, Gillum R, Mussolino M, Hankinson S, Manson J, De Stavola B, Knottenbelt C, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Naito Y, Holme I, Nakagawa H, Miura H, Ducimetiere P, Jouven X, Crespo C, Garcia-Palmieri M, Amouyel P, Arveiler D, Evans A, Ferrieres J, Schulte H, Assmann G, Shepherd J, Packard C, Sattar N, Cantin B, Lamarche B, Després JP, Dagenais GR, Barrett-Connor E, Wingard D, Bettencourt R, Gudnason V, Aspelund T, Sigurdsson G, Thorsson B, Trevisan M, Witteman J, Kardys I, Breteler M, Hofman A, Tunstall-Pedoe H, Tavendale R, Lowe GD, Ben-Shlomo Y, Howard BV, Zhang Y, Best L, Umans J, Onat A, Meade TW, Njolstad I, Mathiesen E, Lochen ML, Wilsgaard T, Gaziano JM, Stampfer M, Ridker P, Ulmer H, Diem G, Concin H, Rodeghiero F, Tosetto A, Brunner E, Shipley M, Buring J, Cobbe SM, Ford I, Robertson M, He Y, Ibanez AM, Feskens EJ, Kromhout D, Collins R, Di Angelantonio E, Kaptoge S, Lewington S, Orfei L, Pennells L, Perry P, Ray K, Sarwar N, Scherman M, Thompson A, Watson S, Wensley F, White IR, Wood AM. The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol. 2007; 22(12):839-69. PMID: 17876711.
    Citations: 55     Fields:    Translation:Humans
  63. Govers-Riemslag JW, Smid M, Cooper JA, Bauer KA, Rosenberg RD, Hack CE, Hamulyak K, Spronk HM, Miller GJ, ten Cate H. The plasma kallikrein-kinin system and risk of cardiovascular disease in men. J Thromb Haemost. 2007 Sep; 5(9):1896-903. PMID: 17723129.
    Citations: 15     Fields:    Translation:Humans
  64. Turpie AG, Bauer KA, Caprini JA, Comp PC, Gent M, Muntz JE. Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost. 2007 Sep; 5(9):1854-61. PMID: 17723125.
    Citations: 20     Fields:    Translation:Humans
  65. Bauer KA. Targeted inhibition of coagulation: oral agents show promise in phase III trials. J Thromb Haemost. 2007 Nov; 5(11):2175-7. PMID: 17764539.
    Citations:    Fields:    Translation:Humans
  66. Silverstein RL, Bauer KA, Cushman M, Esmon CT, Ershler WB, Tracy RP. Venous thrombosis in the elderly: more questions than answers. Blood. 2007 Nov 01; 110(9):3097-101. PMID: 17684155.
    Citations: 14     Fields:    Translation:Humans
  67. Fisher WD, Eriksson BI, Bauer KA, Borris L, Dahl OE, Gent M, Haas S, Homering M, Huisman MV, Kakkar AK, Kälebo P, Kwong LM, Misselwitz F, Turpie AG. Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies. Thromb Haemost. 2007 Jun; 97(6):931-7. PMID: 17549294.
    Citations: 8     Fields:    Translation:Humans
  68. Kocher O, Cirovic C, Malynn E, Rowland CM, Bare LA, Young BA, Henslee JG, Laffler TG, Huff JB, Kruskall MS, Wong G, Bauer KA. Obstetric complications in patients with hereditary thrombophilia identified using the LCx microparticle enzyme immunoassay: a controlled study of 5,000 patients. Am J Clin Pathol. 2007 Jan; 127(1):68-75. PMID: 17145624.
    Citations: 6     Fields:    Translation:Humans
  69. Cushman M, Glynn RJ, Goldhaber SZ, Moll S, Bauer KA, Deitcher S, Shrivastava S, Ridker PM. Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial. J Thromb Haemost. 2006 Oct; 4(10):2199-203. PMID: 16869933.
    Citations: 13     Fields:    Translation:Humans
  70. Pollak ES, Russell TT, Ptashkin B, Smith-Whitley K, Camire RM, Bauer KA. Asymptomatic factor VII deficiency in African Americans. Am J Clin Pathol. 2006 Jul; 126(1):128-32. PMID: 16753603.
    Citations:    Fields:    Translation:Humans
  71. Shrivastava S, Ridker PM, Glynn RJ, Goldhaber SZ, Moll S, Bounameaux H, Bauer KA, Kessler CM, Cushman M. D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. J Thromb Haemost. 2006 Jun; 4(6):1208-14. PMID: 16706961.
    Citations: 17     Fields:    Translation:HumansPHPublic Health
  72. Zwicker JI, Peyvandi F, Palla R, Lombardi R, Canciani MT, Cairo A, Ardissino D, Bernardinelli L, Bauer KA, Lawler J, Mannucci P. The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size. Blood. 2006 Aug 15; 108(4):1280-3. PMID: 16684956.
    Citations: 17     Fields:    Translation:HumansCells
  73. Feinbloom D, Bauer KA. The role of other hemostatic factors in predicting arterial thrombotic events. Arterioscler Thromb Vasc Biol. 2006 Mar; 26(3):e29. PMID: 16484603.
    Citations:    Fields:    Translation:Humans
  74. Bauer KA. New anticoagulants: anti IIa vs anti Xa--is one better? J Thromb Thrombolysis. 2006 Feb; 21(1):67-72. PMID: 16475045.
    Citations: 18     Fields:    Translation:Humans
  75. Bauer KA. New anticoagulants. Hematology Am Soc Hematol Educ Program. 2006; 450-6. PMID: 17124098.
    Citations: 10     Fields:    Translation:Humans
  76. Ireland H, Konstantoulas CJ, Cooper JA, Hawe E, Humphries SE, Mather H, Goodall AH, Hogwood J, Juhan-Vague I, Yudkin JS, di Minno G, Margaglione M, Hamsten A, Miller GJ, Bauer KA, Kim YT, Stearns-Kurosawa DJ, Kurosawa S. EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro. Atherosclerosis. 2005 Dec; 183(2):283-92. PMID: 15921688.
    Citations: 19     Fields:    Translation:HumansAnimals
  77. Turpie AG, Fisher WD, Bauer KA, Kwong LM, Irwin MW, Kälebo P, Misselwitz F, Gent M. BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study. J Thromb Haemost. 2005 Nov; 3(11):2479-86. PMID: 16241946.
    Citations: 51     Fields:    Translation:HumansCTClinical Trials
  78. Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, de Maat MP, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi R, Vahtera E, Jousilahti P, Pekkanen J, D'Agostino R, Kannel WB, Wilson PW, Tofler G, Arocha-Piñango CL, Rodriguez-Larralde A, Nagy E, Mijares M, Espinosa R, Rodriquez-Roa E, Ryder E, Diez-Ewald MP, Campos G, Fernandez V, Torres E, Marchioli R, Valagussa F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen JT, Nyyssönen K, Tuomainen TP, Hedblad B, Lind P, Loewel H, Koenig W, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A, Naito Y, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Després JP, Dagenais GR, Tunstall-Pedoe H, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh JL, Rudnicka A, Ridker P, Rodeghiero F, Tosetto A, Shepherd J, Ford I, Robertson M, Brunner E, Shipley M, Feskens EJ, Kromhout D, Dickinson A, Ireland B, Juzwishin K, Kaptoge S, Lewington S, Memon A, Sarwar N, Walker M, Wheeler J, White I, Wood A. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA. 2005 Oct 12; 294(14):1799-809. PMID: 16219884.
    Citations: 243     Fields:    Translation:Humans
  79. Feinbloom D, Bauer KA. Assessment of hemostatic risk factors in predicting arterial thrombotic events. Arterioscler Thromb Vasc Biol. 2005 Oct; 25(10):2043-53. PMID: 16100033.
    Citations: 25     Fields:    Translation:Humans
  80. Zwicker JI, Uhl L, Huang WY, Shaz BH, Bauer KA. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost. 2004 Dec; 2(12):2133-7. PMID: 15613017.
    Citations: 34     Fields:    Translation:Humans
  81. Miller GJ, Bauer KA, Howarth DJ, Cooper JA, Humphries SE, Rosenberg RD. Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway. J Thromb Haemost. 2004 Dec; 2(12):2107-14. PMID: 15613014.
    Citations: 17     Fields:    Translation:Humans
  82. Bauer KA. Role of thrombophilia in deciding on the duration of anticoagulation. Semin Thromb Hemost. 2004 Dec; 30(6):633-7. PMID: 15630669.
    Citations: 2     Fields:    Translation:Humans
  83. Turpie AG, Eriksson BI, Bauer KA, Lassen MR. Fondaparinux. J Am Acad Orthop Surg. 2004 Nov-Dec; 12(6):371-5. PMID: 15615502.
    Citations:    Fields:    Translation:Humans
  84. Huang WY, Kruskall MS, Bauer KA, Uhl L, Shaz BH. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency. Transfusion. 2004 Nov; 44(11):1562-6. PMID: 15504160.
    Citations: 5     Fields:    Translation:Humans
  85. Lee AY, Gent M, Julian JA, Bauer KA, Eriksson BI, Lassen MR, Turpie AG. Bilateral vs. ipsilateral venography as the primary efficacy outcome measure in thromboprophylaxis clinical trials: a systematic review. J Thromb Haemost. 2004 Oct; 2(10):1752-9. PMID: 15456486.
    Citations: 4     Fields:    Translation:Humans
  86. Bauer KA. Low intensity warfarin: is it clinically useful in venous thromboembolism management? Br J Haematol. 2004 Oct; 127(2):155-8. PMID: 15461620.
    Citations:    Fields:    Translation:Humans
  87. Furie KL, Rosenberg R, Thompson JL, Bauer K, Mohr JP, Rosner B, Sciacca R, Barzegar S, Thornell B, Costigan T, Kistler JP. Thrombin generation in non-cardioembolic stroke subtypes: the Hemostatic System Activation Study. Neurology. 2004 Sep 14; 63(5):777-84. PMID: 15365123.
    Citations: 4     Fields:    Translation:Humans
  88. Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end points. Chest. 2004 Aug; 126(2):501-8. PMID: 15302737.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  89. Pantanowitz L, Bauer K, Tefs K, Schuster V, Balogh K, Pilch BZ, Adcock D, Cirovic C, Kocher O. Ligneous (pseudomembranous) inflammation involving the female genital tract associated with type-1 plasminogen deficiency. Int J Gynecol Pathol. 2004 Jul; 23(3):292-5. PMID: 15213608.
    Citations: 4     Fields:    Translation:Humans
  90. Bauer KA. Fondaparinux: a new synthetic and selective inhibitor of Factor Xa. Best Pract Res Clin Haematol. 2004 Mar; 17(1):89-104. PMID: 15171960.
    Citations: 3     Fields:    Translation:Humans
  91. Vossen CY, Hasstedt SJ, Rosendaal FR, Callas PW, Bauer KA, Broze GJ, Hoogendoorn H, Long GL, Scott BT, Bovill EG. Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C-deficient family. J Thromb Haemost. 2004 Feb; 2(2):242-7. PMID: 14995985.
    Citations: 17     Fields:    Translation:Humans
  92. Turpie AG, Eriksson BI, Bauer KA, Lassen MR. New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies. Chest. 2003 Dec; 124(6 Suppl):371S-378S. PMID: 14668420.
    Citations: 6     Fields:    Translation:Humans
  93. Bauer KA. New pentasaccharides for prophylaxis of deep vein thrombosis: pharmacology. Chest. 2003 Dec; 124(6 Suppl):364S-370S. PMID: 14668419.
    Citations: 3     Fields:    Translation:Humans
  94. Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery. Lancet. 2003 Nov 08; 362(9395):1582-3. PMID: 14615120.
    Citations:    Fields:    Translation:Humans
  95. Carew JA, Basso F, Miller GJ, Hawe E, Jackson AA, Humphries SE, Bauer KA. A functional haplotype in the 5' flanking region of the factor VII gene is associated with an increased risk of coronary heart disease. J Thromb Haemost. 2003 Oct; 1(10):2179-85. PMID: 14521602.
    Citations: 7     Fields:    Translation:HumansCells
  96. Turpie AG, Eriksson BI, Lassen MR, Bauer KA. Fondaparinux, the first selective factor Xa inhibitor. Curr Opin Hematol. 2003 Sep; 10(5):327-32. PMID: 12913785.
    Citations: 8     Fields:    Translation:Humans
  97. Turpie A, Bauer K, Eriksson B, Lassen M. Efficacy and safety of fondaparinux in major orthopedic surgery according to the timing of its first administration. Thromb Haemost. 2003 Aug; 90(2):364-6. PMID: 12888887.
    Citations: 10     Fields:    Translation:Humans
  98. Ardissino D, Merlini PA, Bauer KA, Galvani M, Ottani F, Franchi F, Bertocchi F, Rosenberg RD, Mannucci PM. Coagulation activation and long-term outcome in acute coronary syndromes. Blood. 2003 Oct 15; 102(8):2731-5. PMID: 12843003.
    Citations: 10     Fields:    Translation:HumansCTClinical Trials
  99. Bauer KA. Management of thrombophilia. J Thromb Haemost. 2003 Jul; 1(7):1429-34. PMID: 12871277.
    Citations: 5     Fields:    Translation:Humans
  100. Carew JA, Jackson AA, Bauer KA. ARP1 interacts with the 5' flanking region of the coagulation factor VII gene. J Thromb Haemost. 2003 Jun; 1(6):1220-7. PMID: 12871323.
    Citations:    Fields:    Translation:HumansCells
  101. Konkle BA, Bauer KA, Weinstein R, Greist A, Holmes HE, Bonfiglio J. Use of recombinant human antithrombin in patients with congenital antithrombin deficiency undergoing surgical procedures. Transfusion. 2003 Mar; 43(3):390-4. PMID: 12675726.
    Citations: 7     Fields:    Translation:Humans
  102. Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med. 2003 Apr 10; 348(15):1425-34. PMID: 12601075.
    Citations: 96     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  103. Eriksson BI, Bauer KA, Lassen MR, Turpie AG. Influence of the duration of fondaparinux (Arixtra) prophylaxis in preventing venous thromboembolism following major orthopedic surgery. J Thromb Haemost. 2003 Feb; 1(2):383-4. PMID: 12871516.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  104. Bauer KA. Fondaparinux: basic properties and efficacy and safety in venous thromboembolism prophylaxis. Am J Orthop (Belle Mead NJ). 2002 Nov; 31(11 Suppl):4-10. PMID: 12463577.
    Citations: 1     Fields:    Translation:Humans
  105. Peyvandi F, De Cristofaro R, Akhavan S, Carew JA, Landolfi R, Bauer KA, Mannucci PM. Two naturally occurring mutations on FVII gene (S363I-W364C) altering intrinsic catalytic activity. Thromb Haemost. 2002 Nov; 88(5):750-5. PMID: 12428089.
    Citations:    Fields:    Translation:HumansCells
  106. Press RD, Bauer KA, Kujovich JL, Heit JA. Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med. 2002 Nov; 126(11):1304-18. PMID: 12421138.
    Citations: 18     Fields:    Translation:Humans
  107. Moons AH, Peters RJ, Cate Ht, Bauer KA, Vlasuk GP, Büller HR, Levi M. Recombinant nematode anticoagulant protein c2, a novel inhibitor of tissue factor-factor VIIa activity, abrogates endotoxin-induced coagulation in chimpanzees. Thromb Haemost. 2002 Oct; 88(4):627-31. PMID: 12362234.
    Citations: 7     Fields:    Translation:AnimalsCells
  108. Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med. 2002 Sep 09; 162(16):1833-40. PMID: 12196081.
    Citations: 96     Fields:    Translation:Humans
  109. Bauer KA, Eriksson BI, Lassen MR, Turpie AG. Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism. Curr Opin Pulm Med. 2002 Sep; 8(5):398-404. PMID: 12172443.
    Citations:    Fields:    Translation:HumansAnimals
  110. Cella G, Randi ML, Sbarai A, Bauer KA, Barzega S, Rosenberg RD. Factor IX activation peptide and soluble selectins in patients with chronic myeloproliferative disorders. Haematologica. 2002 Jun; 87(6):671-2. PMID: 12031932.
    Citations:    Fields:    Translation:Humans
  111. Bauer KA. Selective inhibition of coagulation factors: advances in antithrombotic therapy. Semin Thromb Hemost. 2002 Jun; 28 Suppl 2:15-24. PMID: 12073176.
    Citations: 3     Fields:    Translation:HumansCells
  112. Bauer KA. Hormone replacement therapy and the factor V Leiden mutation. Arterioscler Thromb Vasc Biol. 2002 Jun 01; 22(6):879-80. PMID: 12067891.
    Citations:    Fields:    Translation:Humans
  113. Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. Lancet. 2002 May 18; 359(9319):1721-6. PMID: 12049860.
    Citations: 48     Fields:    Translation:HumansCTClinical Trials
  114. Lassen MR, Bauer KA, Eriksson BI, Turpie AG. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lancet. 2002 May 18; 359(9319):1715-20. PMID: 12049858.
    Citations: 47     Fields:    Translation:HumansCTClinical Trials
  115. Miller GJ, Bauer KA, Howarth DJ, Mitchell JP, Cooper JA. Does inflammatory proteolytic activity contribute to the increased factor IX activation peptide in men at high risk of coronary heart disease? A preliminary study. Thromb Haemost. 2002 Mar; 87(3):415-20. PMID: 11916072.
    Citations:    Fields:    Translation:Humans
  116. Turpie AG, Eriksson BI, Lassen MR, Bauer KA. A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery. J South Orthop Assoc. 2002; 11(4):182-8. PMID: 12597061.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  117. Bauer KA, Hawkins DW, Peters PC, Petitou M, Herbert JM, van Boeckel CA, Meuleman DG. Fondaparinux, a synthetic pentasaccharide: the first in a new class of antithrombotic agents - the selective factor Xa inhibitors. Cardiovasc Drug Rev. 2002; 20(1):37-52. PMID: 12070533.
    Citations: 16     Fields:    Translation:HumansAnimals
  118. Bauer KA, Rosendaal FR, Heit JA. Hypercoagulability: too many tests, too much conflicting data. Hematology Am Soc Hematol Educ Program. 2002; 353-68. PMID: 12446432.
    Citations: 3     Fields:    Translation:Humans
  119. Bauer KA, Eriksson BI, Lassen MR, Turpie AG. A new antithrombotic strategy, the selective inhibition of coagulation factors, and its importance to the orthopedic specialist. J South Orthop Assoc. 2002; 11(4):197-202. PMID: 12597063.
    Citations:    Fields:    Translation:Humans
  120. Gilchrist A, Solomon N, Erickson D, Sikand A, Bauer KA, Kruskall MS, Kocher O. Automated detection of the G20210A prothrombin mutation using the LCx microparticle enzyme immunoassay. Clin Chim Acta. 2001 Dec; 314(1-2):249-54. PMID: 11718704.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  121. Eriksson BI, Bauer KA, Lassen MR, Turpie AG. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med. 2001 Nov 01; 345(18):1298-304. PMID: 11794148.
    Citations: 61     Fields:    Translation:HumansCTClinical Trials
  122. Bauer KA, Eriksson BI, Lassen MR, Turpie AG. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med. 2001 Nov 01; 345(18):1305-10. PMID: 11794149.
    Citations: 64     Fields:    Translation:HumansCTClinical Trials
  123. Bauer KA. Fondaparinux sodium: a selective inhibitor of factor Xa. Am J Health Syst Pharm. 2001 Nov 01; 58 Suppl 2:S14-7. PMID: 11715834.
    Citations: 5     Fields:    Translation:Humans
  124. Ardissino D, Merlini PA, Bauer KA, Bramucci E, Ferrario M, Coppola R, Fetiveau R, Lucreziotti S, Rosenberg RD, Mannucci PM. Thrombogenic potential of human coronary atherosclerotic plaques. Blood. 2001 Nov 01; 98(9):2726-9. PMID: 11675344.
    Citations: 5     Fields:    Translation:Humans
  125. Bauer KA. The thrombophilias: well-defined risk factors with uncertain therapeutic implications. Ann Intern Med. 2001 Sep 04; 135(5):367-73. PMID: 11529700.
    Citations: 21     Fields:    
  126. Merlini PA, Rossi ML, Bauer KA. Hemostatic markers and prognosis in ischemic heart disease. Ital Heart J. 2001 Jul; 2(7):499-501. PMID: 11501957.
    Citations:    Fields:    Translation:Humans
  127. Friederich PW, Levi M, Bauer KA, Vlasuk GP, Rote WE, Breederveld D, Keller T, Spataro M, Barzegar S, Büller HR. Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects. Circulation. 2001 May 29; 103(21):2555-9. PMID: 11382723.
    Citations: 8     Fields:    Translation:HumansAnimalsCTClinical Trials
  128. Bauer KA. Conventional fibrinolytic assays for the evaluation of patients with venous thrombosis: don't bother. Thromb Haemost. 2001 Mar; 85(3):377-8. PMID: 11307800.
    Citations:    Fields:    Translation:HumansPHPublic Health
  129. Peyvandi F, Carew JA, Perry DJ, Hunault M, Khanduri U, Perkins SJ, Mannucci PM, Bauer KA. Abnormal secretion and function of recombinant human factor VII as the result of modification to a calcium binding site caused by a 15-base pair insertion in the F7 gene. Blood. 2001 Feb 15; 97(4):960-5. PMID: 11159523.
    Citations:    Fields:    Translation:HumansCells
  130. Daniel V, Huber W, Bauer K, Suesal C, Mytilineos J, Melk A, Conradt C, Opelz G. Association of elevated blood levels of pentachlorophenol (PCP) with cellular and humoral immunodeficiencies. Arch Environ Health. 2001 Jan-Feb; 56(1):77-83. PMID: 11256860.
    Citations: 11     Fields:    Translation:HumansPHPublic Health
  131. Carew JA, Pollak ES, Lopaciuk S, Bauer KA. A new mutation in the HNF4 binding region of the factor VII promoter in a patient with severe factor VII deficiency. Blood. 2000 Dec 15; 96(13):4370-2. PMID: 11110717.
    Citations: 2     Fields:    Translation:HumansCells
  132. Cooper JA, Miller GJ, Bauer KA, Morrissey JH, Meade TW, Howarth DJ, Barzegar S, Mitchell JP, Rosenberg RD. Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease. Circulation. 2000 Dec 05; 102(23):2816-22. PMID: 11104738.
    Citations: 21     Fields:    Translation:Humans
  133. Minnema MC, Peters RJ, de Winter R, Lubbers YP, Barzegar S, Bauer KA, Rosenberg RD, Hack CE, ten Cate H. Activation of clotting factors XI and IX in patients with acute myocardial infarction. Arterioscler Thromb Vasc Biol. 2000 Nov; 20(11):2489-93. PMID: 11073857.
    Citations: 17     Fields:    Translation:Humans
  134. Bauer KA. Venous thromboembolism in malignancy. J Clin Oncol. 2000 Sep; 18(17):3065-7. PMID: 10963634.
    Citations: 3     Fields:    Translation:Humans
  135. Bauer KA, Humphries S, Smillie B, Li L, Cooper JA, Barzegar S, Rosenberg RD, Miller GJ. Prothrombin activation is increased among asymptomatic carriers of the prothrombin G20210A and factor V Arg506Gln mutations. Thromb Haemost. 2000 Sep; 84(3):396-400. PMID: 11019961.
    Citations: 1     Fields:    Translation:Humans
  136. Merlini PA, Ardissino D, Rosenberg RD, Colombi E, Agricola P, Oltrona L, Ottani F, Galvani M, Bauer KA, Bottasso B, Bertocchi F, Mannucci PM. In vivo thrombin generation and activity during and after intravenous infusion of heparin or recombinant hirudin in patients with unstable angina pectoris. Arterioscler Thromb Vasc Biol. 2000 Sep; 20(9):2162-6. PMID: 10978264.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  137. Bovill EG, Hasstedt SJ, Callas PW, Valliere JE, Scott BT, Bauer KA, Long GL. The G20210A prothrombin polymorphism is not associated with increased thromboembolic risk in a large protein C deficient kindred. Thromb Haemost. 2000 Mar; 83(3):366-70. PMID: 10744139.
    Citations: 2     Fields:    Translation:Humans
  138. Hunault M, Bauer KA. Recombinant factor VIIa for the treatment of congenital factor VII deficiency. Semin Thromb Hemost. 2000; 26(4):401-5. PMID: 11092215.
    Citations: 5     Fields:    Translation:Humans
  139. Bauer KA. Activation markers of coagulation. Baillieres Best Pract Res Clin Haematol. 1999 Sep; 12(3):387-406. PMID: 10856977.
    Citations: 2     Fields:    Translation:HumansAnimals
  140. Hunault M, Arbini AA, Carew JA, Bauer KA. Mechanism underlying factor VII deficiency in Jewish populations with the Ala244Val mutation. Br J Haematol. 1999 Jun; 105(4):1101-8. PMID: 10554827.
    Citations:    Fields:    Translation:Humans
  141. Xu X, Bauer KA, Griffin JH. Two multiplex PCR-based DNA assays for the thrombosis risk factors prothrombin G20210A and coagulation factor V G1691A polymorphisms. Thromb Res. 1999 Mar 15; 93(6):265-9. PMID: 10093967.
    Citations: 2     Fields:    Translation:Humans
  142. Wulf GM, Van Deerlin VM, Leonard DG, Bauer KA. Thrombosis in a patient with combined homozygosity for the factor V Leiden mutation and a mutation in the 3'-untranslated region of the prothrombin gene. Blood Coagul Fibrinolysis. 1999 Mar; 10(2):107-10. PMID: 10192660.
    Citations: 2     Fields:    Translation:Humans
  143. Hunault M, Arbini AA, Carew JA, Peyvandi F, Bauer KA. Characterization of two naturally occurring mutations in the second epidermal growth factor-like domain of factor VII. Blood. 1999 Feb 15; 93(4):1237-44. PMID: 9949166.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  144. Hunault M, Marsh-Scott C, Jou C, Marshall R, Scheffel C, Fiore LD, Bauer KA, Mitchell MJ. Automated detection of the factor V Leiden mutation using the LCx microparticle enzyme immunoassay. Clin Chem. 1999 Jan; 45(1):41-6. PMID: 9895336.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  145. Carew JA, Pollak ES, High KA, Bauer KA. Severe factor VII deficiency due to a mutation disrupting an Sp1 binding site in the factor VII promoter. Blood. 1998 Sep 01; 92(5):1639-45. PMID: 9716591.
    Citations: 5     Fields:    Translation:HumansCells
  146. Miller GJ, Bauer KA, Cooper JA, Rosenberg RD. Activation of the coagulant pathway in cigarette smokers. Thromb Haemost. 1998 Mar; 79(3):549-53. PMID: 9531038.
    Citations: 16     Fields:    Translation:Humans
  147. Hunault M, Arbini AA, Lopaciuk S, Carew JA, Bauer KA. The Arg353Gln polymorphism reduces the level of coagulation factor VII. In vivo and in vitro studies. Arterioscler Thromb Vasc Biol. 1997 Nov; 17(11):2825-9. PMID: 9409261.
    Citations: 8     Fields:    Translation:HumansAnimalsCells
  148. Merlini PA, Ardissino D, Bauer KA, Oltrona L, Pezzano A, Bottasso B, Rosenberg RD, Mannucci PM. Persistent thrombin generation during heparin therapy in patients with acute coronary syndromes. Arterioscler Thromb Vasc Biol. 1997 Jul; 17(7):1325-30. PMID: 9261263.
    Citations: 4     Fields:    Translation:HumansCells
  149. Bauer KA. Activation of the factor VII-tissue factor pathway. Thromb Haemost. 1997 Jul; 78(1):108-11. PMID: 9198137.
    Citations: 2     Fields:    Translation:Humans
  150. Arbini AA, Pollak ES, Bayleran JK, High KA, Bauer KA. Severe factor VII deficiency due to a mutation disrupting a hepatocyte nuclear factor 4 binding site in the factor VII promoter. Blood. 1997 Jan 01; 89(1):176-82. PMID: 8978290.
    Citations: 5     Fields:    Translation:HumansCells
  151. Bauer KA. [Treatment and prevention of thrombotic episodes with hereditary thrombophilia]. Vestn Ross Akad Med Nauk. 1997; (1):32-7. PMID: 9064020.
    Citations:    Fields:    Translation:Humans
  152. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited thrombophilia: Part 2. Thromb Haemost. 1996 Dec; 76(6):824-34. PMID: 8971998.
    Citations: 24     Fields:    Translation:Humans
  153. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited thrombophilia: Part 1. Thromb Haemost. 1996 Nov; 76(5):651-62. PMID: 8950768.
    Citations: 57     Fields:    Translation:HumansAnimalsCells
  154. Silveira A, Karpe F, Johnsson H, Bauer KA, Hamsten A. In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway. Arterioscler Thromb Vasc Biol. 1996 Nov; 16(11):1333-9. PMID: 8911271.
    Citations: 3     Fields:    Translation:Humans
  155. Arbini AA, Mannucci M, Bauer KA. A Thr359Met mutation in factor VII of a patient with a hereditary deficiency causes defective secretion of the molecule. Blood. 1996 Jun 15; 87(12):5085-94. PMID: 8652821.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  156. Miller GJ, Bauer KA, Barzegar S, Cooper JA, Rosenberg RD. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease. Thromb Haemost. 1996 May; 75(5):767-71. PMID: 8725721.
    Citations: 18     Fields:    Translation:Humans
  157. ten Cate H, Biemond BJ, Levi M, Wuillemin WA, Bauer KA, Barzegar S, Buller HR, Hack CE, ten Cate JW, Rosenberg RD. Factor XIa induced activation of the intrinsic cascade in vivo. Thromb Haemost. 1996 Mar; 75(3):445-9. PMID: 8701405.
    Citations: 3     Fields:    Translation:HumansAnimals
  158. van Boven HH, Reitsma PH, Rosendaal FR, Bayston TA, Chowdhury V, Bauer KA, Scharrer I, Conard J, Lane DA. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thromb Haemost. 1996 Mar; 75(3):417-21. PMID: 8701400.
    Citations: 15     Fields:    Translation:Humans
  159. Bauer KA. Treatment of factor VII deficiency with recombinant factor VIIa. Haemostasis. 1996; 26 Suppl 1:155-8. PMID: 8904192.
    Citations: 1     Fields:    Translation:Humans
  160. Bauer KA, Eichinger S, Mannucci PM, Rosenberg RD. Determinants of coagulation activation in humans. Haemostasis. 1996; 26 Suppl 1:72-5. PMID: 8904177.
    Citations:    Fields:    Translation:Humans
  161. Cohen LJ, McWilliams NB, Neuberg R, Zinkham W, Bauer K, Gribble TJ, Glowalla MB, Borson R, Phillips MD, Kunschak M. Prophylaxis and therapy with factor VII concentrate (human) immuno, vapor heated in patients with congenital factor VII deficiency: a summary of case reports. Am J Hematol. 1995 Dec; 50(4):269-76. PMID: 7485101.
    Citations: 4     Fields:    Translation:HumansCells
  162. Arbini AA, Mannucci PM, Bauer KA. Low prevalence of the factor V Leiden mutation among "severe" hemophiliacs with a "milder" bleeding diathesis. Thromb Haemost. 1995 Nov; 74(5):1255-8. PMID: 8607105.
    Citations: 3     Fields:    Translation:Humans
  163. Merlini PA, Ardissino D, Bauer KA, Oltrona L, Spinola A, Diotallevi P, Rosenberg RD, Mannucci PM. Activation of the hemostatic mechanism during thrombolysis in patients with unstable angina pectoris. Blood. 1995 Nov 01; 86(9):3327-32. PMID: 7579435.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  164. Eichinger S, Mannucci PM, Tradati F, Arbini AA, Rosenberg RD, Bauer KA. Determinants of plasma factor VIIa levels in humans. Blood. 1995 Oct 15; 86(8):3021-5. PMID: 7579395.
    Citations: 4     Fields:    Translation:HumansCells
  165. Váradi K, Moritz B, Lang H, Bauer K, Preston E, Peake I, Rivard GE, Keil B, Schwarz HP. A chromogenic assay for activated protein C resistance. Br J Haematol. 1995 Aug; 90(4):884-91. PMID: 7669667.
    Citations:    Fields:    Translation:Humans
  166. Bauer KA. Management of patients with hereditary defects predisposing to thrombosis including pregnant women. Thromb Haemost. 1995 Jul; 74(1):94-100. PMID: 8578533.
    Citations: 1     Fields:    Translation:Humans
  167. Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, Rosenberg RD. Hypercoagulability in centenarians: the paradox of successful aging. Blood. 1995 Jun 01; 85(11):3144-9. PMID: 7756646.
    Citations: 33     Fields:    Translation:HumansCells
  168. Schmaier AH, Dahl LD, Hasan AA, Cines DB, Bauer KA, Van Nostrand WE. Factor IXa inhibition by protease nexin-2/amyloid beta-protein precursor on phospholipid vesicles and cell membranes. Biochemistry. 1995 Jan 31; 34(4):1171-8. PMID: 7827067.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  169. Merlini PA, Bauer KA, Oltrona L, Ardissino D, Spinola A, Cattaneo M, Broccolino M, Mannucci PM, Rosenberg RD. Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction. J Am Coll Cardiol. 1995 Jan; 25(1):203-9. PMID: 7798503.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  170. Miller GJ, Bauer KA, Barzegar S, Foley AJ, Mitchell JP, Cooper JA, Rosenberg RD. The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men. Thromb Haemost. 1995 Jan; 73(1):82-6. PMID: 7740501.
    Citations: 21     Fields:    Translation:Humans
  171. Greengard JS, Eichinger S, Griffin JH, Bauer KA. Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg-->Gln mutation in the gene for factor V. N Engl J Med. 1994 Dec 08; 331(23):1559-62. PMID: 7969326.
    Citations: 9     Fields:    Translation:HumansCells
  172. Arbini AA, Bodkin D, Lopaciuk S, Bauer KA. Molecular analysis of Polish patients with factor VII deficiency. Blood. 1994 Oct 01; 84(7):2214-20. PMID: 7919338.
    Citations: 4     Fields:    Translation:HumansCells
  173. Bauer KA. New markers for in vivo coagulation. Curr Opin Hematol. 1994 Sep; 1(5):341-6. PMID: 9371303.
    Citations:    Fields:    Translation:Humans
  174. Bauer KA, Rosenberg RD. Activation markers of coagulation. Baillieres Clin Haematol. 1994 Sep; 7(3):523-40. PMID: 7841599.
    Citations: 1     Fields:    Translation:HumansAnimals
  175. Mannucci PM, Bauer KA, Santagostino E, Faioni E, Barzegar S, Coppola R, Rosenberg RD. Activation of the coagulation cascade after infusion of a factor XI concentrate in congenitally deficient patients. Blood. 1994 Aug 15; 84(4):1314-9. PMID: 8049446.
    Citations: 5     Fields:    Translation:Humans
  176. Merlini PA, Bauer KA, Oltrona L, Ardissino D, Cattaneo M, Belli C, Mannucci PM, Rosenberg RD. Persistent activati